Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)
Clinical trial NCT01649622 · WITHDRAWN
Trial details
- NCT number
- NCT01649622
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2018-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.